Can you tell us about your projects within the PreciDIAB National Center? How will these allow advances in research and the care of diabetic patients?
Some projects currently implemented within the framework of PreciDIAB gravitate directly around the diabetic patient. Indeed, the success of these projects depends first of all on the recruitment of patients in order to encourage them to participate in these prospective cohorts*.
A good example is “PreciDIAB Heart and Brain” whose objective is to predict cardiac dysfunction and the onset of cognitive disorders in type 2 diabetes. This cohort will study the mechanisms involved in cardiac immunomodulation, myocardial mechanics and cognition.
In addition, we participate directly in the reflection of projects that are centered on the institution such as the development of strategies for the prevention of iatrogenia* using computerized decision support systems, in particular with the team of Prof. Jean-Baptiste Beuscart. The development of this project will make it possible to better detect and correct situations at iatrogenic risk and/or requiring therapeutic optimization in hospitalized patients in connection with the outpatient department* and the patient.
Other projects are being prepared, such as the genotyping of patients with gestational diabetes in order to identify those most at risk of becoming diabetic and requiring special follow-up. All of these projects will allow a better understanding of the mechanisms involved in diabetes and will be very useful in the context of medical care, but also for the training of all the actors who gravitate around the patient.